$0.57
-0.03 (-5.09%)
Open$0.62
Previous Close$0.60
Day High$0.63
Day Low$0.57
52W High$9.70
52W Low$1.75
Volume—
Avg Volume11.2K
Market Cap6.48M
P/E Ratio—
EPS$-2.06
SectorPharmaceuticals
Analyst Ratings
Strong Buy
7 analysts
Price Target
+522.0% upside
Current
$0.57
$0.57
Target
$3.54
$3.54
$2.21
$3.54 avg
$4.26
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 165.54M | 141.92M | 4.60M |
| Net Income | -32,430,840 | -25,023,796 | 612.3K |
| Profit Margin | -19.6% | -18.6% | 13.3% |
| EBITDA | -28,882,435 | -23,523,931 | 960.1K |
| Free Cash Flow | — | — | 405.9K |
| Rev Growth | +16.6% | +16.6% | +11.5% |
| Debt/Equity | 3.44 | 3.44 | 0.89 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $916.31 | +1.47% | 46.4 | 957.52B |
| JNJ | Johnson & Johnson | $239.93 | +1.98% | 22.2 | 594.00B |
| MRK | Merck & Co. Inc. | $119.37 | +2.58% | 16.5 | 301.17B |
| PFE | Pfizer Inc. | $27.28 | +1.19% | 19.7 | 153.36B |
| BMY | Bristol-Myers Squibb Co | $58.94 | +2.70% | 16.5 | 116.58B |
| ZTS | Zoetis Inc | $116.71 | +0.67% | 21.5 | 57.37B |